Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Renewal Deadline
193 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-01-17)
Due Date
January 17, 2026
Grace Period Ends
July 17, 2026
Application History
43 eventsDate | Code | Type | Description |
---|---|---|---|
Feb 21, 2025 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Jan 17, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Jul 7, 2020 | NOSU | I | NOTICE OF SUIT |
Jun 26, 2020 | NOSU | I | NOTICE OF SUIT |
Apr 10, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Apr 10, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Apr 10, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Apr 10, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Apr 10, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Jun 10, 2015 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Apr 15, 2015 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Apr 15, 2015 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Apr 15, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Apr 15, 2015 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Apr 1, 2015 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Feb 9, 2015 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Feb 9, 2015 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Jul 25, 2012 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Feb 7, 2012 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Feb 7, 2012 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Feb 7, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Dec 19, 2011 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
Jan 7, 2010 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jan 7, 2010 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jan 17, 2006 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Oct 25, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION |
Oct 5, 2005 | NPUB | O | NOTICE OF PUBLICATION |
Jul 15, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Jul 1, 2005 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jul 1, 2005 | IUAA | P | USE AMENDMENT ACCEPTED |
Jun 10, 2005 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jun 10, 2005 | ALIE | A | ASSIGNED TO LIE |
Jun 1, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jun 1, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Dec 9, 2004 | GNRT | F | NON-FINAL ACTION E-MAILED |
Dec 9, 2004 | CNRT | R | NON-FINAL ACTION WRITTEN |
Dec 9, 2004 | DOCK | D | ASSIGNED TO EXAMINER |
Aug 19, 2004 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE |
Aug 19, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
Aug 11, 2004 | IUAF | S | USE AMENDMENT FILED |
Aug 11, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 11, 2004 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED |
May 19, 2004 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals, namely pharmaceutical preparations for the treatment of human immunodeficiency virus, or HIV, inflammatory disorders, cancer and diabetes
First Use Anywhere:
Jul 15, 2004
First Use in Commerce:
Jul 15, 2004
Classification
International Classes
005